Remove Dermatology Remove Document Remove Treatments
article thumbnail

PHysicians & the esthetician

Southeastern Esthetics Institute

Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. Having daily and weekly communication when dealing with patients receiving treatment is critical.

article thumbnail

Self-Skin Cancer Exams: Early Detection and When to See a Dermatologist

US Dermatologt Partners

Dermatology Partners Georgetown , Skin cancer is a condition that ranges in severity from highly treatable to life-threatening. Fortunately, early detection dramatically improves treatment outcomes. Take notes or photos document any moles, spots, or lesions for easy comparison over time. Dermatology Partners.

article thumbnail

New DART Guidelines Set Standards for Use of IGSRT in Non-melanoma Skin Cancers

The Dermatology Digest

New guidelines from the Dermatology Association of Radiation Therapy (DART) call for standardized dosing and fractions when treating basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) patients with image-guided superficial radiation therapy (IGSRT).

Surgery 74
article thumbnail

The Top 5 Dermatology Trends on Instagram and TikTok

First Derm

The Top 5 Dermatology Trends on Instagram and TikTok Dermatology is one of the most popular medical fields on Instagram and TikTok. From skin care tips to spot treatments, people are constantly looking for new information and advice about how to take care of their skin. They are eager to give them a try.

article thumbnail

DART: Medicare Administrative Contractor’s Coverage Proposal on IGSRT Will Jeopardize Progress, Patient Outcomes

The Dermatology Digest

The Dermatology Association of Radiation Therapy (DART) is urging dermatologists and other stakeholders to oppose a proposed policy that would cancel Medicare coverage for image-guided superficial radiation therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer in seven states.

Therapy 81
article thumbnail

Incyte’s Povorcitinib Hits Primary Endpoints in Phase 3 HS Studies

The Dermatology Digest

Given the limitations of current HS treatments and its impact on patients daily lives, there is a critical need for new, well tolerated and effective therapies that provide a rapid reduction in the signs and symptoms of HS, in particular, pain,” says Steven Stein, MD, Chief Medical Officer at Incyte, in a news release.

Safety 36
article thumbnail

Documented Atopic Dermatitis Journeys and Patient Perspectives in Germany

Dermatology Times

The study focused on the use of Internet resources, number of medical consultations, and factors influencing treatment outcomes.